Absci (ABSI) FCF Margin (QoQ) (2020 - 2026)
Absci (ABSI) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -777,608.00 |
| Dec 31, 2025 | 240,276.00 |
| Sep 30, 2025 | -399,349.00 |
| Jun 30, 2025 | -102,852.00 |
| Mar 31, 2025 | 74,645.00 |
| Dec 31, 2024 | -139,743.00 |
| Sep 30, 2024 | 14,897.00 |
| Jun 30, 2024 | 63,676.00 |
| Mar 31, 2024 | 242,559.00 |
| Dec 31, 2023 | -303,267.00 |
| Sep 30, 2023 | -81,230.00 |
| Jun 30, 2023 | 102,553.00 |
| Mar 31, 2023 | -72,809.00 |
| Dec 31, 2022 | 808,288.00 |
| Sep 30, 2022 | -682,569.00 |
| Jun 30, 2022 | 456,897.00 |
| Mar 31, 2022 | -731,571.00 |
| Dec 31, 2021 | 143,840.00 |
| Sep 30, 2021 | 449,021.00 |
| Jun 30, 2021 | -462,400.00 |